Morning Watch List : Bristol-Myers Squibb (NYSE:BMY), The Procter & Gamble (NYSE:PG), Nordic American Offshore (NYSE:NAO), Infinera (NASDAQ:INFN), Dr. Reddy’s Laboratories (NYSE:RDY),

Bristol-Myers Squibb Company (NYSE:BMY) announced Tuesday its plans to build a 650,000-square-foot office building in the township at the intersection of Princeton Pike and Interstate 95. Bristol-Myers Squibb Company (NYSE:BMY) belongs to Healthcare sector. Its net profit margin is 16.60% and weekly performance is 0.98%. On last trading day company shares ended up $51.62. Bristol-Myers Squibb Company (NYSE:BMY) distance from 50-day simple moving average (SMA50) is 2.92%.

The Procter & Gamble Company (NYSE:PG) is reportedly the focus of a Mexican investigation into whether the Cincinnati-based company might owe millions of dollars in back taxes. The Procter & Gamble Company (NYSE:PG) shares moved down -1.07% in last trading session and ended the day at $84.33. PG Gross Margin is 48.90% and its return on assets is 8.00%. The Procter & Gamble Company (NYSE:PG) quarterly performance is 7.26%.

On Sep 8, Nordic American Offshore Ltd. (NYSE:NAO) has entered into two new contracts with a major oil-company in the UK for one year with a one year option, the company said in its press release. On 25 September, Nordic American Offshore Ltd. (NYSE:NAO) shares moved down -0.61% and was closed at $17.90. NAO EPS growth in last 5 year was 0.00%. Nordic American Offshore Ltd. (NYSE:NAO) year to date (YTD) performance is 20.95%.

Infinera Corp. (NASDAQ:INFN) President David F. Welch unloaded 22,500 shares of the company’s stock on the open market in a transaction dated Monday, September 22nd. The shares were sold at an average price of $11.20, for a total transaction of $252,000.00. Following the sale, the president now directly owns 14,132 shares of the company’s stock, valued at approximately $158,278. Infinera Corporation (NASDAQ:INFN) ended the last trading day at $10.74. Company weekly volatility is calculated as 3.50% and price to cash ratio as 4.23. Infinera Corporation (NASDAQ:INFN) showed a weekly performance of -7.09%.

Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) has launched its generic version of Sunovion Pharmaceuticals Inc.’s Xopenex inhalation solution (0.31 mg/3 mL, 0.63 mg/3 mL, 1.25 mg/3 mL unit-dose vials) in the U.S. It can be used only with a nebulizer. Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) shares advanced 0.17% in last trading session and ended the day at $53.35. RDY Gross Margin is 57.40% and its return on assets is 20.60%. Dr. Reddy’s Laboratories Ltd. (NYSE:RDY) quarterly performance is 27.78%.